The Combination of Lanraplenib, a Selective SYK Inhibitor, and Gilteritinib, a FLT3 Inhibitor, Targets Aberrant Proliferation and Differentiation Blockade in Acute Myeloid Leukemia

被引：2
|
作者：
Carvajal, Luis A. [1 ]
McKeown, Michael R. [2 ]
Hood, Tressa [2 ]
Guo, Linlin [2 ]
Lin, Charles Y. [2 ]
DiMartino, Jorge F. [1 ]
机构：
[1] Kronos Bio Inc, San Mateo, CA USA
[2] Kronos Bio Inc, Cambridge, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
616
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Evaluation of a FLT3 inhibitor as an anti-leukemic agent for acute myeloid leukemia
    Jeong, Pyeonghwa
    Lee, Jungeun
    Lee, Hyo Jeong
    Baek, Juhwa
    Choi, Jungil
    Chin, Young-Won
    Choi, Young Hee
    Kim, Yong-Chul
    Han, Sun-Young
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [32] FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
    Kiyoi, Hitoshi
    Kawashima, Naomi
    Ishikawa, Yuichi
    CANCER SCIENCE, 2020, 111 (02) : 312 - 322
  • [33] Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
    Abhishek Maiti
    Courtney D. DiNardo
    Naval G. Daver
    Caitlin R. Rausch
    Farhad Ravandi
    Tapan M. Kadia
    Naveen Pemmaraju
    Gautam Borthakur
    Prithviraj Bose
    Ghayas C. Issa
    Nicholas J. Short
    Musa Yilmaz
    Guillermo Montalban-Bravo
    Alessandra Ferrajoli
    Elias J. Jabbour
    Nitin Jain
    Maro Ohanian
    Koichi Takahashi
    Philip A. Thompson
    Sanam Loghavi
    Kathryn S. Montalbano
    Sherry Pierce
    William G. Wierda
    Hagop M. Kantarjian
    Marina Y. Konopleva
    Blood Cancer Journal, 11
  • [34] Sweet's syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor
    Paudel, Anish
    Dhital, Rashmi
    Areoye, Gabriel
    Basnet, Sijan
    Tachamo, Niranjan
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2020, 10 (03): : 275 - 278
  • [35] PHI-101, a next generation FLT3 inhibitor for acute myeloid leukemia
    Nam, Ky-Youb
    Im, Jeejin
    Yoon, JeongHyeok
    Young, David
    Li, Li
    Zhu, Ruiqi
    Bao Nguyen
    Small, Donald
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
    Maiti, Abhishek
    DiNardo, Courtney D.
    Daver, Naval G.
    Rausch, Caitlin R.
    Ravandi, Farhad
    Kadia, Tapan M.
    Pemmaraju, Naveen
    Borthakur, Gautam
    Bose, Prithviraj
    Issa, Ghayas C.
    Short, Nicholas J.
    Yilmaz, Musa
    Montalban-Bravo, Guillermo
    Ferrajoli, Alessandra
    Jabbour, Elias J.
    Jain, Nitin
    Ohanian, Maro
    Takahashi, Koichi
    Thompson, Philip A.
    Loghavi, Sanam
    Montalbano, Kathryn S.
    Pierce, Sherry
    Wierda, William G.
    Kantarjian, Hagop M.
    Konopleva, Marina Y.
    BLOOD CANCER JOURNAL, 2021, 11 (02)
  • [37] Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia
    Wang, Eunice S.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 105 - 112
  • [38] Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
    Zhang, Weiguo
    Yu, Guopan
    Zhang, Hongying
    Basyal, Mahesh
    Ly, Charlie
    Yuan, Bin
    Ruvolo, Vivian
    Piya, Sujan
    Bhattacharya, Seemana
    Zhang, Qi
    Borthakur, Gautam
    Battula, Venkata L.
    Konopleva, Marina
    Rice, William G.
    Andreeff, Michael
    HAEMATOLOGICA, 2023, 108 (06) : 1500 - 1514
  • [39] Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors
    Numan, Yazan
    Abdel Rahman, Zaid
    Grenet, Justin
    Boisclair, Stephanie
    Bewersdorf, Jan Philipp
    Collins, Cailin
    Barth, Dylan
    Fraga, Martina
    Bixby, Dale L.
    Zeidan, Amer M.
    Yilmaz, Musa
    Desai, Pankil
    Mannis, Gabriel
    Deutsch, Yehuda E.
    Abaza, Yasmin
    Dinner, Shira
    Frankfurt, Olga
    Litzow, Mark
    Al-Kali, Aref
    Foran, James M.
    Sproat, Lisa Z.
    Jovanovic, Borko
    Daver, Naval
    Perl, Alexander E.
    Altman, Jessica K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : 322 - 328
  • [40] Venetoclax in Combination with Gilteritinib Demonstrates Molecular Clearance of FLT3 mutation in Relapsed/Refractory FLT3Mutated Acute Myeloid Leukemia
    Daver, Naval
    Perl, Alexander E.
    Maly, Joseph
    Levis, Mark
    Ritchie, Ellen
    Litzow, Mark R.
    McCloskey, James
    Smith, Catherine C.
    Schiller, Gary J.
    Bradley, Terrence
    Tiu, Ramon V.
    Naqvi, Kiran
    Dail, Monique
    Siddani, Satya
    Wang, Jing
    Chyla, Brenda
    Lee, Paul
    Altman, Jessica K.
    BLOOD, 2021, 138
12345